Taxane-platinum combination chemotherapy versus single agent platinum for the first-line treatment of epithelial ovarian cancer
Editorial Group: Cochrane Gynaecological Cancer Group
Published Online: 12 DEC 2012
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Johnson N, Miles T, Cornes P, Gilby E. Taxane-platinum combination chemotherapy versus single agent platinum for the first-line treatment of epithelial ovarian cancer (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 12. Art. No.: CD010194. DOI: 10.1002/14651858.CD010194.
- Publication Status: Edited (no change to conclusions)
- Published Online: 12 DEC 2012
This is the protocol for a review and there is no abstract. The objectives are as follows:
To evaluate the benefit and harms of adding a taxane to platinum therapy compared to platinum chemotherapy alone for the primary management of epithelial ovarian, fallopian tube or peritoneal epithelial adenocarcinoma.